Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Cancer-Related Pain: Prevalence, Severity and Management in a Tertiary Care Center in the Middle East

Hamieh NM, Akel R, Anouti B, Traboulsi C, Makki I, Hamieh L, Tfayli A.

Asian Pac J Cancer Prev. 2018 Mar 27;19(3):769-775.

2.

Prevalence and Severity of Sleep Disturbances among Patients with Early Breast Cancer.

Fakih R, Rahal M, Hilal L, Hamieh L, Dany M, Karam S, Shehab L, El Saghir NS, Tfayli A, Salem Z, Assi H, Temraz S, Shamseddine A, Mukherji D.

Indian J Palliat Care. 2018 Jan-Mar;24(1):35-38. doi: 10.4103/IJPC.IJPC_137_17.

3.

Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events.

Martini DJ, Hamieh L, McKay RR, Harshman LC, Brandao R, Norton CK, Steinharter JA, Krajewski KM, Gao X, Schutz FA, McGregor B, Bossé D, Lalani AA, De Velasco G, Michaelson MD, McDermott DF, Choueiri TK.

Cancer Immunol Res. 2018 Apr;6(4):402-408. doi: 10.1158/2326-6066.CIR-17-0220. Epub 2018 Feb 1.

PMID:
29437040
4.

Characterization of Patients With Poor-Risk Metastatic Renal-Cell Carcinoma: Results From a Pooled Clinical Trials Database.

Hamieh L, McKay RR, Lin X, Simantov R, Choueiri TK.

Clin Genitourin Cancer. 2017 Aug 12. pii: S1558-7673(17)30231-8. doi: 10.1016/j.clgc.2017.07.021. [Epub ahead of print]

PMID:
28918175
5.

Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma.

de Velasco G, Gray KP, Hamieh L, Urun Y, Carol HA, Fay AP, Signoretti S, Kwiatkowski DJ, McDermott DF, Freedman M, Pomerantz MM, Choueiri TK.

Eur Urol Focus. 2016 Dec 15;2(6):633-639. doi: 10.1016/j.euf.2016.03.017. Epub 2016 Apr 23.

6.

Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab.

Moreira RB, Hamieh L, Gjini E, Lako A, Krajewski KM, Yoon CH, Ott PA.

J Immunother Cancer. 2017 Jul 18;5(1):61. doi: 10.1186/s40425-017-0259-9.

7.

Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort.

El Chediak A, Alameddine RS, Hakim A, Hilal L, Abdel Massih S, Hamieh L, Mukherji D, Temraz S, Charafeddine M, Shamseddine A.

Breast Cancer (Dove Med Press). 2017 Jun 10;9:407-414. doi: 10.2147/BCTT.S130273. eCollection 2017.

8.

Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit.

Tarhini AA, Lin Y, Lin HM, Vallabhaneni P, Sander C, LaFramboise W, Hamieh L.

Oncoimmunology. 2016 Sep 19;6(2):e1231291. doi: 10.1080/2162402X.2016.1231291. eCollection 2017.

9.

Pancreatic PEComa is a novel member of the family of tuberous sclerosis complex-associated tumors: case report and review of the literature.

Hartley CP, Kwiatkowski DJ, Hamieh L, Lefferts JA, Smith KD, Lisovsky M.

Virchows Arch. 2016 Dec;469(6):707-710. Epub 2016 Oct 18. Review. No abstract available.

PMID:
27757534
10.

Effect of Metformin Use on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma.

Hamieh L, McKay RR, Lin X, Moreira RB, Simantov R, Choueiri TK.

Clin Genitourin Cancer. 2017 Apr;15(2):221-229. doi: 10.1016/j.clgc.2016.06.017. Epub 2016 Jun 29.

PMID:
27460432
11.

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.

Kwiatkowski DJ, Choueiri TK, Fay AP, Rini BI, Thorner AR, de Velasco G, Tyburczy ME, Hamieh L, Albiges L, Agarwal N, Ho TH, Song J, Pignon JC, Barrios PM, Michaelson MD, Van Allen E, Krajewski KM, Porta C, Pal S, Bellmunt J, McDermott DF, Heng DYC, Gray KP, Signoretti S.

Clin Cancer Res. 2016 May 15;22(10):2445-2452. doi: 10.1158/1078-0432.CCR-15-2631. Epub 2016 Feb 1.

12.

Nipple Angiofibromas with Loss of TSC2 Are Associated with Tuberous Sclerosis Complex.

Nathan N, Tyburczy ME, Hamieh L, Wang JA, Brown GT, Richard Lee CC, Kwiatkowski DJ, Moss J, Darling TN.

J Invest Dermatol. 2016 Feb;136(2):535-8. doi: 10.1016/j.jid.2015.11.015. Epub 2015 Dec 10. No abstract available.

13.

Leptomeningeal metastasis as initial manifestation of signet ring colorectal adenocarcinoma: a case report with review of literature.

Assi R, Hamieh L, Mukherji D, Haydar A, Temraz S, El-Dika I, Shamseddine A.

J Gastrointest Oncol. 2015 Dec;6(6):E89-E101. doi: 10.3978/j.issn.2078-6891.2015.087.

14.

Optimizing systemic therapy for metastatic renal cell carcinoma beyond the first-line setting.

de Velasco G, Hamieh L, Mickey S, Choueiri TK.

Urol Oncol. 2015 Dec;33(12):538-45. doi: 10.1016/j.urolonc.2015.08.007. Epub 2015 Oct 9. Review.

15.

From sprouting angiogenesis to erythrocytes generation by cancer stem cells: evolving concepts in tumor microcirculation.

Alameddine RS, Hamieh L, Shamseddine A.

Biomed Res Int. 2014;2014:986768. doi: 10.1155/2014/986768. Epub 2014 Aug 4. Review.

16.

Role of PARP inhibitors in cancer biology and therapy.

Davar D, Beumer JH, Hamieh L, Tawbi H.

Curr Med Chem. 2012;19(23):3907-21. Review.

Supplemental Content

Loading ...
Support Center